Case Report

Published on 23 Sep 2022

Case Report: Neoadjuvant immunotherapy with pembrolizumab alone for bilateral upper tract urothelial carcinoma is a feasible strategy for kidney sparing and avoidance of hemodialysis

in Genitourinary Oncology

Wai-Nga Chan
Yun-Ching Huang
Dong-Ru Ho
Chih-Shou Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.985177

1,766 views
1 citation

Technology and Code

Published on 23 Sep 2022

Combining prostate-specific antigen density with prostate imaging reporting and data system score version 2.1 to improve detection of clinically significant prostate cancer: A retrospective study

in Genitourinary Oncology

Yin Lei
Tian Jie Li
Peng Gu
Yu kun Yang
Lei Zhao
Chao Gao
Juan Hu
Xiao Dong Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.992032

2,119 views
1 citation

Original Research

Published on 23 Sep 2022

Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific

in Genitourinary Oncology

Brian Duggan
Declan O’Rourke
Neil Anderson
Cherith N. Reid
Joanne Watt
Hugh O’Kane
Ruth Boyd
David Curry
Mark Evans
Michael Stevenson

Frontiers in Oncology

doi 10.3389/fonc.2022.1009014

2,569 views
4 citations

Original Research

Published on 23 Sep 2022

Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer

in Genitourinary Oncology

Sahyun Pak
Jungyo Suh
Seo Young Park
Yunlim Kim
Yong Mee Cho
Hanjong Ahn

Frontiers in Oncology

doi 10.3389/fonc.2022.972572

2,643 views
5 citations

Original Research

Published on 23 Sep 2022

Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate cancer

in Genitourinary Oncology

Shu-Hui Hsu
Zhaohui Han
Jonathan E. Leeman
Yue-Houng Hu
Raymond H. Mak
Atchar Sudhyadhom

Frontiers in Oncology

doi 10.3389/fonc.2022.969463

4,240 views
25 citations

Original Research

Published on 23 Sep 2022

The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis

in Genitourinary Oncology

Sara Elena Rebuzzi
Alessio Signori
Marco Stellato
Daniele Santini
Marco Maruzzo
Ugo De Giorgi
Paolo Pedrazzoli
Luca Galli
Paolo Andrea Zucali
Emanuela Fantinel

Frontiers in Oncology

doi 10.3389/fonc.2022.955501

2,632 views
10 citations

Review

Published on 23 Sep 2022

To bind or not to bind: Cistromic reprogramming in prostate cancer

in Genitourinary Oncology

Michelle Shen
Léa-Kristine Demers
Swneke D. Bailey
David P. Labbé

Frontiers in Oncology

doi 10.3389/fonc.2022.963007

4,315 views
8 citations

Original Research

Published on 21 Sep 2022

Pathological diagnostic nomograms for predicting malignant histology and unfavorable pathology in patients with endophytic renal tumor

in Genitourinary Oncology

Xinxi Deng
Xiaoqiang Liu
Bing Hu
Ming Jiang
Ke Zhu
Jianqiang Nie
Taobin Liu
Luyao Chen
Wen Deng
Bin Fu

Frontiers in Oncology

doi 10.3389/fonc.2022.964048

1,514 views
3 citations

Editorial

Published on 21 Sep 2022

Editorial: Evidence and emerging option in diagnosis and management of upper tract urothelial carcinomas

in Genitourinary Oncology

Liangren Liu
Yige Bao
Chengfei Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1038356

681 views

Original Research

Published on 20 Sep 2022

GLUD1 suppresses renal tumorigenesis and development via inhibiting PI3K/Akt/mTOR pathway

in Genitourinary Oncology

Lei Wang
Zhiyu Fang
Peixiang Gao
Junfang Zheng

Frontiers in Oncology

doi 10.3389/fonc.2022.975517

3,927 views
8 citations

Original Research

Published on 16 Sep 2022

The top 100 most-cited papers in pheochromocytomas and paragangliomas: A bibliometric study

in Genitourinary Oncology

Sai-Li Duan
Lin Qi
Ming-Hao Li
Long-Fei Liu
Yong Wang
Xiao Guan

Frontiers in Oncology

doi 10.3389/fonc.2022.993921

2,192 views
4 citations

Review

Published on 16 Sep 2022

Testicular tumors in the “elderly” population

in Genitourinary Oncology

Simona Secondino
Giovanni Rosti
Antonino C. Tralongo
Franco Nolè
Domiziana Alaimo
Ornella Carminati
Richard Lawrence John Naspro
Paolo Pedrazzoli

Frontiers in Oncology

doi 10.3389/fonc.2022.972151

11,354 views
6 citations

Case Report

Published on 16 Sep 2022

Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report

in Genitourinary Oncology

Tsukasa Yoshida
Hiroshi Yaegashi
Ren Toriumi
Suguru Kadomoto
Hiroaki Iwamoto
Kouji Izumi
Yoshifumi Kadono
Hiroko Ikeda
Atsushi Mizokami

Frontiers in Oncology

doi 10.3389/fonc.2022.912490

2,729 views
9 citations

Original Research

Published on 16 Sep 2022

The values of systemic immune-inflammation index and neutrophil-lymphocyte ratio in predicting testicular germ cell tumors: A retrospective clinical study

in Genitourinary Oncology

Shuo Wang
Xiao Yang
Ziyi Yu
Peng Du
Yudong Cao
Yongpeng Ji
Jinchao Ma
Yong Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.893877

2,089 views
6 citations

Original Research

Published on 15 Sep 2022

Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA

in Genitourinary Oncology

Umang Swami
Raquel Mae Zimmerman
Roberto H. Nussenzveig
Edgar Javier Hernandez
Yeonjung Jo
Nicolas Sayegh
Sergiusz Wesolowski
Lesli A. Kiedrowski
Pedro C. Barata
Gordon Howard Lemmon

Frontiers in Oncology

doi 10.3389/fonc.2022.966534

3,689 views
2 citations

Original Research

Published on 14 Sep 2022

Mutational signature and clonal relatedness of recurrent urothelial carcinomas with aristolochic acid

in Genitourinary Oncology

Jie Zhu
Qing Ai
Qiang Cheng
Dan Shen
Zhouhuan Dong
Jie Li
Donglai Shen
Wei Wang
Xu Zhang
Hongzhao Li

Frontiers in Oncology

doi 10.3389/fonc.2022.990023

1,351 views

Navigation group

Articles

Case Report: Neoadjuvant immunotherapy with pembrolizumab alone for bilateral upper tract urothelial carcinoma is a feasible strategy for kidney sparing and avoidance of hemodialysis

Combining prostate-specific antigen density with prostate imaging reporting and data system score version 2.1 to improve detection of clinically significant prostate cancer: A retrospective study

Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific

Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer

Synthetic CT generation for MRI-guided adaptive radiotherapy in prostate cancer

The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis

To bind or not to bind: Cistromic reprogramming in prostate cancer

Pathological diagnostic nomograms for predicting malignant histology and unfavorable pathology in patients with endophytic renal tumor

Editorial: Evidence and emerging option in diagnosis and management of upper tract urothelial carcinomas

GLUD1 suppresses renal tumorigenesis and development via inhibiting PI3K/Akt/mTOR pathway

The top 100 most-cited papers in pheochromocytomas and paragangliomas: A bibliometric study

Testicular tumors in the “elderly” population

Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report

The values of systemic immune-inflammation index and neutrophil-lymphocyte ratio in predicting testicular germ cell tumors: A retrospective clinical study

Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA

Mutational signature and clonal relatedness of recurrent urothelial carcinomas with aristolochic acid